Author:
Fukui Hiroshi,Koike Tomohiro,Nakagawa Takashi,Saheki Akira,Sonoke Satoru,Tomii Yoshifumi,Seki Junzo
Reference29 articles.
1. Development, characterization, efficacy and mode of action of AmBisome®, a unilamellar liposomal formulation of amphotericin B;Adler-Moore;J. Liposome Res.,1993
2. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience;Adler-Moore;J. Antimicrob. Chemother.,2002
3. Amphotericin B pharmacokinetics in humans;Atkinson;Antimicrob. Agents Chemother.,1978
4. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990;Beck-Sagué;J. Infect. Dis.,1993
5. Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome®) in beagle dogs;Bekersky;Pharm. Res.,1999
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献